The ethics of creating GMO humans
By Editorial Board,
Los Angeles Times
| 08. 03. 2017
In a process that can be likened to the creation of GMO crops, scientists have edited genes in human embryos in order to eliminate a mutation that causes thickening of the heart wall. The embryos were created solely for the scientists’ study and will not be implanted. Nonetheless, the research offers hope that in years ahead, science could prevent many serious genetic diseases at the stage in which people are a microscopic cluster of cells in a petri dish. What’s more, because those edited genes would be carried forth into new generations, the disease might eventually be eliminated altogether.
Is this a glorious new frontier or a troubling situation? Unequivocally, the answer is yes to both.
The research results by an international team of U.S., Chinese and South Korean scientists were enormously exciting medically. Beyond the technical achievement involved, the team’s work hastened the arrival of a revolutionary form of treatment: removing genes that can lead inexorably to suffering and premature death.
But there is also a great deal we still don’t know about how minor issues might become major...
Related Articles
Alice Wong, founder of the Disability Visibility Project, MacArthur Genius, liberationist, storyteller, writer, and friend of CGS, died on November 14. Alice shone a bright light on pervasive ableism in our society. She articulated how people with disabilities are limited not by an inability to do things but by systemic segregation and discrimination, the de-prioritization of accessibility, and the devaluation of their lives.
We at CGS learned so much from Alice about disability justice, which goes beyond rights...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...